These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Cisplatin-mediated c-myc overexpression and cytochrome c (cyt c) release result in the up-regulation of the death receptors DR4 and DR5 and the activation of caspase 3 and caspase 9, likely responsible for the TRAIL-sensitizing effect of cisplatin. Zhu X; Zhang K; Wang Q; Chen S; Gou Y; Cui Y; Li Q Med Oncol; 2015 Apr; 32(4):133. PubMed ID: 25796504 [TBL] [Abstract][Full Text] [Related]
25. COX-2 inhibitors sensitize human hepatocellular carcinoma cells to TRAIL-induced apoptosis. Yamanaka Y; Shiraki K; Inoue T; Miyashita K; Fuke H; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T Int J Mol Med; 2006 Jul; 18(1):41-7. PubMed ID: 16786154 [TBL] [Abstract][Full Text] [Related]
26. Spatial dynamics of TRAIL death receptors in cancer cells. Twomey JD; Kim SR; Zhao L; Bozza WP; Zhang B Drug Resist Updat; 2015 Mar; 19():13-21. PubMed ID: 25840763 [TBL] [Abstract][Full Text] [Related]
27. Downmodulation of dimethyl transferase activity enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in prostate cancer cells. Festuccia C; Gravina GL; D'Alessandro AM; Millimaggi D; Di Rocco C; Dolo V; Ricevuto E; Vicentini C; Bologna M Int J Oncol; 2008 Aug; 33(2):381-8. PubMed ID: 18636160 [TBL] [Abstract][Full Text] [Related]
28. Combined inhibition of DNA methyltransferase and histone deacetylase restores caspase-8 expression and sensitizes SCLC cells to TRAIL. Kaminskyy VO; Surova OV; Vaculova A; Zhivotovsky B Carcinogenesis; 2011 Oct; 32(10):1450-8. PubMed ID: 21771726 [TBL] [Abstract][Full Text] [Related]
29. Anti-gout agent allopurinol exerts cytotoxicity to human hormone-refractory prostate cancer cells in combination with tumor necrosis factor-related apoptosis-inducing ligand. Yasuda T; Yoshida T; Goda AE; Horinaka M; Yano K; Shiraishi T; Wakada M; Mizutani Y; Miki T; Sakai T Mol Cancer Res; 2008 Dec; 6(12):1852-60. PubMed ID: 19074830 [TBL] [Abstract][Full Text] [Related]
31. The cyclin-dependent kinase inhibitor flavopiridol sensitizes human hepatocellular carcinoma cells to TRAIL-induced apoptosis. Miyashita K; Shiraki K; Fuke H; Inoue T; Yamanaka Y; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T Int J Mol Med; 2006 Aug; 18(2):249-56. PubMed ID: 16820931 [TBL] [Abstract][Full Text] [Related]
32. Histone deacetylase inhibitors strongly sensitise neuroblastoma cells to TRAIL-induced apoptosis by a caspases-dependent increase of the pro- to anti-apoptotic proteins ratio. Mühlethaler-Mottet A; Flahaut M; Bourloud KB; Auderset K; Meier R; Joseph JM; Gross N BMC Cancer; 2006 Aug; 6():214. PubMed ID: 16930472 [TBL] [Abstract][Full Text] [Related]
33. Antitumor agent parthenolide reverses resistance of breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through sustained activation of c-Jun N-terminal kinase. Nakshatri H; Rice SE; Bhat-Nakshatri P Oncogene; 2004 Sep; 23(44):7330-44. PubMed ID: 15286701 [TBL] [Abstract][Full Text] [Related]
34. The three Rs along the TRAIL: resistance, re-sensitization and reactive oxygen species (ROS). Mellier G; Pervaiz S Free Radic Res; 2012 Aug; 46(8):996-1003. PubMed ID: 22559302 [TBL] [Abstract][Full Text] [Related]
35. Drug-mediated sensitization to TRAIL-induced apoptosis in caspase-8-complemented neuroblastoma cells proceeds via activation of intrinsic and extrinsic pathways and caspase-dependent cleavage of XIAP, Bcl-xL and RIP. Mühlethaler-Mottet A; Bourloud KB; Auderset K; Joseph JM; Gross N Oncogene; 2004 Jul; 23(32):5415-25. PubMed ID: 15094781 [TBL] [Abstract][Full Text] [Related]
36. The histone deacetylase inhibitor trichostatin a decreases lymphangiogenesis by inducing apoptosis and cell cycle arrest via p21-dependent pathways. Hrgovic I; Doll M; Kleemann J; Wang XF; Zoeller N; Pinter A; Kippenberger S; Kaufmann R; Meissner M BMC Cancer; 2016 Sep; 16(1):763. PubMed ID: 27716272 [TBL] [Abstract][Full Text] [Related]
38. Induction and regulation of tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand-mediated apoptosis in renal cell carcinoma. Griffith TS; Fialkov JM; Scott DL; Azuhata T; Williams RD; Wall NR; Altieri DC; Sandler AD Cancer Res; 2002 Jun; 62(11):3093-9. PubMed ID: 12036919 [TBL] [Abstract][Full Text] [Related]
39. Pterostilbene Enhances TRAIL-Induced Apoptosis through the Induction of Death Receptors and Downregulation of Cell Survival Proteins in TRAIL-Resistance Triple Negative Breast Cancer Cells. Hung CM; Liu LC; Ho CT; Lin YC; Way TD J Agric Food Chem; 2017 Dec; 65(51):11179-11191. PubMed ID: 29164887 [TBL] [Abstract][Full Text] [Related]
40. Targeting TNF-related apoptosis-inducing ligand (TRAIL) receptor by natural products as a potential therapeutic approach for cancer therapy. Dai X; Zhang J; Arfuso F; Chinnathambi A; Zayed ME; Alharbi SA; Kumar AP; Ahn KS; Sethi G Exp Biol Med (Maywood); 2015 Jun; 240(6):760-73. PubMed ID: 25854879 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]